NYSE:DLB - Dolby Laboratories Stock Price, Price Target & More

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories declared a quarterly dividend on Tuesday, April 24th. Investors of record on Monday, May 7th will be given a dividend of $0.16 per share on Wednesday, May 16th. This represents a $0.64 annualized dividend and a yield of 1.04%. The ex-dividend date of this dividend is Friday, May 4th. View Dolby Laboratories' Dividend History.

Dolby Laboratories announced that its Board of Directors has authorized a stock repurchase plan on Sunday, April 9th 2017, which authorizes the company to buyback $200,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 3.9% of its shares through open market purchases. Shares buyback plans are often an indication that the company's management believes its shares are undervalued.

Dolby Laboratories, Inc. (NYSE:DLB) issued its earnings results on Tuesday, April, 24th. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.64 by $0.14. The electronics maker had revenue of $301.36 million for the quarter, compared to analyst estimates of $300.37 million. Dolby Laboratories had a return on equity of 12.73% and a net margin of 7.64%. The business's revenue for the quarter was up 12.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.63 earnings per share. View Dolby Laboratories' Earnings History.

Dolby Laboratories is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for Dolby Laboratories.

Dolby Laboratories issued an update on its third quarter earnings guidance on Tuesday, April, 24th. The company provided earnings per share guidance of $0.78-0.84 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.97. The company issued revenue guidance of $310-320 million, compared to the consensus revenue estimate of $330.43 million.

5 brokerages have issued 12 month target prices for Dolby Laboratories' stock. Their predictions range from $52.00 to $78.00. On average, they expect Dolby Laboratories' share price to reach $65.20 in the next twelve months. View Analyst Ratings for Dolby Laboratories.

Some companies that are related to Dolby Laboratories include InterDigital (IDCC), TiVo (TIVO), RPX (RPXC), Acacia Research (ACTG), Quarterhill (QTRH), Liberty Tax (TAX), Digital Turbine (APPS), The Joint (JYNT), MGT Capital Investments (MGTI), Finjan (FNJN), Copytele (ITUS), XCel Brands (XELB), Marathon Patent Group (MARA), Research Frontiers (REFR) and ARC Group (ARCK).

News articles about DLB stock have been trending very positive this week, according to Accern. The research group rates the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Dolby Laboratories earned a coverage optimism score of 0.65 on Accern's scale. They also gave media stories about the electronics maker an impact score of 46.69 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Dolby Laboratories' stock is owned by a number of of retail and institutional investors. Top institutional investors include DOLBY DAGMAR (41.00%), BlackRock Inc. (2.87%), American Century Companies Inc. (1.44%), Allianz Asset Management GmbH (1.12%), Allianz Asset Management GmbH (1.12%) and Thrivent Financial for Lutherans (0.92%). Company insiders that own Dolby Laboratories stock include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Michael Bergeron, N William Jasper, Jr, Nicholas Donatiello Jr, Nicholas Donatiello, Jr, Peter C Gotcher and Steven E Forshay. View Institutional Ownership Trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Schroder Investment Management Group, American Century Companies Inc., JPMorgan Chase & Co., OppenheimerFunds Inc., UBS Group AG, BlackRock Inc. and Polar Asset Management Partners Inc.. Company insiders that have sold Dolby Laboratories company stock in the last year include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr, Nicholas Donatiello Jr, Peter C Gotcher and Steven E Forshay. View Insider Buying and Selling for Dolby Laboratories.

DLB stock was purchased by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, Allianz Asset Management GmbH, Summit Trail Advisors LLC, DekaBank Deutsche Girozentrale, Columbus Circle Investors, Fiera Capital Corp, Blair William & Co. IL and Wells Fargo & Company MN. View Insider Buying and Selling for Dolby Laboratories.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DLB stock can currently be purchased for approximately $61.63.

Dolby Laboratories has a market capitalization of $6.40 billion and generates $1.08 billion in revenue each year. The electronics maker earns $201.80 million in net income (profit) each year or $2.20 on an earnings per share basis. Dolby Laboratories employs 2,122 workers across the globe.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]